Kaynes Technology India

KAYNES · NSE · Electronics Manufacturing · India

Revenue (FY2026)

₹3,626 Cr

Net margin

10.0%

New to these? P/E, ROE, ROCE and more in Learn.

Ask MarketChacha about KAYNES

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Jul 9, 2026

    Kaynes Technology shares rose sharply as EMS stocks rallied after the government waived basic customs duty on key electronics manufacturing components (display assemblies, lithium-ion cells, inductor coil modules) until March 31, 2029.

  • Jul 8, 2026

    No specific catalyst identified in recent filings or credible coverage for the decline; the stock appears to have moved with broader market or sector sentiment amid ongoing discussions around its semiconductor growth prospects.

    · confidence: low
  • Jul 3, 2026

    No clear company-specific catalyst from the July 2 board meeting outcome (routine internal auditor appointment and management change filing); the stock rose alongside broader India semiconductor sector momentum noted in coverage.

    · confidence: low
  • Jun 29, 2026

    Kaynes Technology shares fell with no identifiable company-specific catalyst or filing on June 29; the move appears to reflect broader market or sector sentiment following earlier Q4 results weakness.

    · confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Revenue trend

Yearly

PeriodRevenueNet profitNet margin
FY2026₹3,626 Cr₹364 Cr10.0%
FY2025₹2,722 Cr₹293 Cr10.8%
FY2024₹1,805 Cr₹183 Cr10.2%
FY2023₹1,126 Cr

Quarterly

PeriodRevenueNet profitNet margin
2026Q1₹1,243 Cr₹91 Cr7.3%
2025Q4₹804 Cr₹77 Cr9.5%
2025Q3₹906 Cr₹121 Cr13.4%
2025Q2₹673 Cr₹75 Cr11.1%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

In the news

Education and discussion only — not investment advice. Data from official filings (SEC/BSE), reported company financials, and news — not live exchange quotes. Verify with the linked sources before acting.